Bellicum Pharmaceuticals

Alexza Pharmaceuticals

Alexza Pharmaceuticals is a rapidly emerging pharmaceutical company focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system, or CNS conditions. Acquired by Grupo Ferrer Internacional in 2016.

Select Venture Capital & Financial Partners

5AM Ventures Abingworth Management Alloy Ventures Azimuth Opportunity, L.P. Burrill & Company CMEA Ventures Delphi Ventures Frazier Healthcare Ventures Glynn Capital Management Lumira Capital MDS Capital New Enterprise Associates Pac Rim Venture Partners T. Rowe Price Associates Versant Ventures West River Capital Zesiger Capital Group, LLC
www.alexza.com